CD4 and hepatocellular carcinoma: Wang and colleagues observed that in the non-alcoholic steatohepatitis-hepatocellular carcinoma model (NASH-HCC model, STAM) the overall number of CD4+ T cells dropped while the number of Tregs sharply increased coincident with more severe tumor burden.